Global Transdermal Drug Delivery System Market Size, Status and Forecast 2023

Report ID: 1234743 | Published Date: Jan 2025 | No. of Page: 119 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Transdermal Drug Delivery System Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Fentanyl
        1.2.3 Nitroglycerin
        1.2.4 Estradiol
        1.2.5 Nicotine
        1.2.6 Other
    1.3 Market by Application
        1.3.1 Global Transdermal Drug Delivery System Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 OTC
        1.3.3 Rx
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Transdermal Drug Delivery System Market Perspective (2016-2027)
    2.2 Transdermal Drug Delivery System Growth Trends by Regions
        2.2.1 Transdermal Drug Delivery System Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Transdermal Drug Delivery System Historic Market Share by Regions (2016-2021)
        2.2.3 Transdermal Drug Delivery System Forecasted Market Size by Regions (2022-2027)
    2.3 Transdermal Drug Delivery System Industry Dynamic
        2.3.1 Transdermal Drug Delivery System Market Trends
        2.3.2 Transdermal Drug Delivery System Market Drivers
        2.3.3 Transdermal Drug Delivery System Market Challenges
        2.3.4 Transdermal Drug Delivery System Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Transdermal Drug Delivery System Players by Revenue
        3.1.1 Global Top Transdermal Drug Delivery System Players by Revenue (2016-2021)
        3.1.2 Global Transdermal Drug Delivery System Revenue Market Share by Players (2016-2021)
    3.2 Global Transdermal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Transdermal Drug Delivery System Revenue
    3.4 Global Transdermal Drug Delivery System Market Concentration Ratio
        3.4.1 Global Transdermal Drug Delivery System Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Transdermal Drug Delivery System Revenue in 2020
    3.5 Transdermal Drug Delivery System Key Players Head office and Area Served
    3.6 Key Players Transdermal Drug Delivery System Product Solution and Service
    3.7 Date of Enter into Transdermal Drug Delivery System Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Transdermal Drug Delivery System Breakdown Data by Type
    4.1 Global Transdermal Drug Delivery System Historic Market Size by Type (2016-2021)
    4.2 Global Transdermal Drug Delivery System Forecasted Market Size by Type (2022-2027)

5 Transdermal Drug Delivery System Breakdown Data by Application
    5.1 Global Transdermal Drug Delivery System Historic Market Size by Application (2016-2021)
    5.2 Global Transdermal Drug Delivery System Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Transdermal Drug Delivery System Market Size (2016-2027)
    6.2 North America Transdermal Drug Delivery System Market Size by Type
        6.2.1 North America Transdermal Drug Delivery System Market Size by Type (2016-2021)
        6.2.2 North America Transdermal Drug Delivery System Market Size by Type (2022-2027)
        6.2.3 North America Transdermal Drug Delivery System Market Size by Type (2016-2027)
    6.3 North America Transdermal Drug Delivery System Market Size by Application
        6.3.1 North America Transdermal Drug Delivery System Market Size by Application (2016-2021)
        6.3.2 North America Transdermal Drug Delivery System Market Size by Application (2022-2027)
        6.3.3 North America Transdermal Drug Delivery System Market Size by Application (2016-2027)
    6.4 North America Transdermal Drug Delivery System Market Size by Country
        6.4.1 North America Transdermal Drug Delivery System Market Size by Country (2016-2021)
        6.4.2 North America Transdermal Drug Delivery System Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Transdermal Drug Delivery System Market Size (2016-2027)
    7.2 Europe Transdermal Drug Delivery System Market Size by Type
        7.2.1 Europe Transdermal Drug Delivery System Market Size by Type (2016-2021)
        7.2.2 Europe Transdermal Drug Delivery System Market Size by Type (2022-2027)
        7.2.3 Europe Transdermal Drug Delivery System Market Size by Type (2016-2027)
    7.3 Europe Transdermal Drug Delivery System Market Size by Application
        7.3.1 Europe Transdermal Drug Delivery System Market Size by Application (2016-2021)
        7.3.2 Europe Transdermal Drug Delivery System Market Size by Application (2022-2027)
        7.3.3 Europe Transdermal Drug Delivery System Market Size by Application (2016-2027)
    7.4 Europe Transdermal Drug Delivery System Market Size by Country
        7.4.1 Europe Transdermal Drug Delivery System Market Size by Country (2016-2021)
        7.4.2 Europe Transdermal Drug Delivery System Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Transdermal Drug Delivery System Market Size (2016-2027)
    8.2 Asia-Pacific Transdermal Drug Delivery System Market Size by Type
        8.2.1 Asia-Pacific Transdermal Drug Delivery System Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Transdermal Drug Delivery System Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Transdermal Drug Delivery System Market Size by Type (2016-2027)
    8.3 Asia-Pacific Transdermal Drug Delivery System Market Size by Application
        8.3.1 Asia-Pacific Transdermal Drug Delivery System Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Transdermal Drug Delivery System Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Transdermal Drug Delivery System Market Size by Application (2016-2027)
    8.4 Asia-Pacific Transdermal Drug Delivery System Market Size by Region
        8.4.1 Asia-Pacific Transdermal Drug Delivery System Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Transdermal Drug Delivery System Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Transdermal Drug Delivery System Market Size (2016-2027)
    9.2 Latin America Transdermal Drug Delivery System Market Size by Type
        9.2.1 Latin America Transdermal Drug Delivery System Market Size by Type (2016-2021)
        9.2.2 Latin America Transdermal Drug Delivery System Market Size by Type (2022-2027)
        9.2.3 Latin America Transdermal Drug Delivery System Market Size by Type (2016-2027)
    9.3 Latin America Transdermal Drug Delivery System Market Size by Application
        9.3.1 Latin America Transdermal Drug Delivery System Market Size by Application (2016-2021)
        9.3.2 Latin America Transdermal Drug Delivery System Market Size by Application (2022-2027)
        9.3.3 Latin America Transdermal Drug Delivery System Market Size by Application (2016-2027)
    9.4 Latin America Transdermal Drug Delivery System Market Size by Country
        9.4.1 Latin America Transdermal Drug Delivery System Market Size by Country (2016-2021)
        9.4.2 Latin America Transdermal Drug Delivery System Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Transdermal Drug Delivery System Market Size (2016-2027)
    10.2 Middle East & Africa Transdermal Drug Delivery System Market Size by Type
        10.2.1 Middle East & Africa Transdermal Drug Delivery System Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Transdermal Drug Delivery System Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Transdermal Drug Delivery System Market Size by Type (2016-2027)
    10.3 Middle East & Africa Transdermal Drug Delivery System Market Size by Application
        10.3.1 Middle East & Africa Transdermal Drug Delivery System Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Transdermal Drug Delivery System Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Transdermal Drug Delivery System Market Size by Application (2016-2027)
    10.4 Middle East & Africa Transdermal Drug Delivery System Market Size by Country
        10.4.1 Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Hisamitsu
        11.1.1 Hisamitsu Company Details
        11.1.2 Hisamitsu Business Overview
        11.1.3 Hisamitsu Transdermal Drug Delivery System Introduction
        11.1.4 Hisamitsu Revenue in Transdermal Drug Delivery System Business (2016-2021)
        11.1.5 Hisamitsu Recent Development
    11.2 Mylan
        11.2.1 Mylan Company Details
        11.2.2 Mylan Business Overview
        11.2.3 Mylan Transdermal Drug Delivery System Introduction
        11.2.4 Mylan Revenue in Transdermal Drug Delivery System Business (2016-2021)
        11.2.5 Mylan Recent Development
    11.3 GSK
        11.3.1 GSK Company Details
        11.3.2 GSK Business Overview
        11.3.3 GSK Transdermal Drug Delivery System Introduction
        11.3.4 GSK Revenue in Transdermal Drug Delivery System Business (2016-2021)
        11.3.5 GSK Recent Development
    11.4 Novartis
        11.4.1 Novartis Company Details
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Transdermal Drug Delivery System Introduction
        11.4.4 Novartis Revenue in Transdermal Drug Delivery System Business (2016-2021)
        11.4.5 Novartis Recent Development
    11.5 Teve (Actavis)
        11.5.1 Teve (Actavis) Company Details
        11.5.2 Teve (Actavis) Business Overview
        11.5.3 Teve (Actavis) Transdermal Drug Delivery System Introduction
        11.5.4 Teve (Actavis) Revenue in Transdermal Drug Delivery System Business (2016-2021)
        11.5.5 Teve (Actavis) Recent Development
    11.6 Johnson & Johnson
        11.6.1 Johnson & Johnson Company Details
        11.6.2 Johnson & Johnson Business Overview
        11.6.3 Johnson & Johnson Transdermal Drug Delivery System Introduction
        11.6.4 Johnson & Johnson Revenue in Transdermal Drug Delivery System Business (2016-2021)
        11.6.5 Johnson & Johnson Recent Development
    11.7 Lohmann
        11.7.1 Lohmann Company Details
        11.7.2 Lohmann Business Overview
        11.7.3 Lohmann Transdermal Drug Delivery System Introduction
        11.7.4 Lohmann Revenue in Transdermal Drug Delivery System Business (2016-2021)
        11.7.5 Lohmann Recent Development
    11.8 Teikoku Seiyaku
        11.8.1 Teikoku Seiyaku Company Details
        11.8.2 Teikoku Seiyaku Business Overview
        11.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Introduction
        11.8.4 Teikoku Seiyaku Revenue in Transdermal Drug Delivery System Business (2016-2021)
        11.8.5 Teikoku Seiyaku Recent Development
    11.9 Bayer
        11.9.1 Bayer Company Details
        11.9.2 Bayer Business Overview
        11.9.3 Bayer Transdermal Drug Delivery System Introduction
        11.9.4 Bayer Revenue in Transdermal Drug Delivery System Business (2016-2021)
        11.9.5 Bayer Recent Development
    11.10 Lingrui
        11.10.1 Lingrui Company Details
        11.10.2 Lingrui Business Overview
        11.10.3 Lingrui Transdermal Drug Delivery System Introduction
        11.10.4 Lingrui Revenue in Transdermal Drug Delivery System Business (2016-2021)
        11.10.5 Lingrui Recent Development
    11.11 Sanofi
        11.11.1 Sanofi Company Details
        11.11.2 Sanofi Business Overview
        11.11.3 Sanofi Transdermal Drug Delivery System Introduction
        11.11.4 Sanofi Revenue in Transdermal Drug Delivery System Business (2016-2021)
        11.11.5 Sanofi Recent Development
    11.12 Qizheng
        11.12.1 Qizheng Company Details
        11.12.2 Qizheng Business Overview
        11.12.3 Qizheng Transdermal Drug Delivery System Introduction
        11.12.4 Qizheng Revenue in Transdermal Drug Delivery System Business (2016-2021)
        11.12.5 Qizheng Recent Development
    11.13 Endo
        11.13.1 Endo Company Details
        11.13.2 Endo Business Overview
        11.13.3 Endo Transdermal Drug Delivery System Introduction
        11.13.4 Endo Revenue in Transdermal Drug Delivery System Business (2016-2021)
        11.13.5 Endo Recent Development
    11.14 Huarun 999
        11.14.1 Huarun 999 Company Details
        11.14.2 Huarun 999 Business Overview
        11.14.3 Huarun 999 Transdermal Drug Delivery System Introduction
        11.14.4 Huarun 999 Revenue in Transdermal Drug Delivery System Business (2016-2021)
        11.14.5 Huarun 999 Recent Development
    11.15 Haw Par
        11.15.1 Haw Par Company Details
        11.15.2 Haw Par Business Overview
        11.15.3 Haw Par Transdermal Drug Delivery System Introduction
        11.15.4 Haw Par Revenue in Transdermal Drug Delivery System Business (2016-2021)
        11.15.5 Haw Par Recent Development
    11.16 Nichiban
        11.16.1 Nichiban Company Details
        11.16.2 Nichiban Business Overview
        11.16.3 Nichiban Transdermal Drug Delivery System Introduction
        11.16.4 Nichiban Revenue in Transdermal Drug Delivery System Business (2016-2021)
        11.16.5 Nichiban Recent Development
    11.17 Mentholatum
        11.17.1 Mentholatum Company Details
        11.17.2 Mentholatum Business Overview
        11.17.3 Mentholatum Transdermal Drug Delivery System Introduction
        11.17.4 Mentholatum Revenue in Transdermal Drug Delivery System Business (2016-2021)
        11.17.5 Mentholatum Recent Development
    11.18 Laboratoires Genevrier
        11.18.1 Laboratoires Genevrier Company Details
        11.18.2 Laboratoires Genevrier Business Overview
        11.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Introduction
        11.18.4 Laboratoires Genevrier Revenue in Transdermal Drug Delivery System Business (2016-2021)
        11.18.5 Laboratoires Genevrier Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Transdermal Drug Delivery System Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Fentanyl
    Table 3. Key Players of Nitroglycerin
    Table 4. Key Players of Estradiol
    Table 5. Key Players of Nicotine
    Table 6. Key Players of Other
    Table 7. Global Transdermal Drug Delivery System Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Transdermal Drug Delivery System Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Transdermal Drug Delivery System Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global Transdermal Drug Delivery System Market Share by Regions (2016-2021)
    Table 11. Global Transdermal Drug Delivery System Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global Transdermal Drug Delivery System Market Share by Regions (2022-2027)
    Table 13. Transdermal Drug Delivery System Market Trends
    Table 14. Transdermal Drug Delivery System Market Drivers
    Table 15. Transdermal Drug Delivery System Market Challenges
    Table 16. Transdermal Drug Delivery System Market Restraints
    Table 17. Global Transdermal Drug Delivery System Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global Transdermal Drug Delivery System Market Share by Players (2016-2021)
    Table 19. Global Top Transdermal Drug Delivery System Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Drug Delivery System as of 2020)
    Table 20. Ranking of Global Top Transdermal Drug Delivery System Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by Transdermal Drug Delivery System Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Transdermal Drug Delivery System Product Solution and Service
    Table 24. Date of Enter into Transdermal Drug Delivery System Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Transdermal Drug Delivery System Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global Transdermal Drug Delivery System Revenue Market Share by Type (2016-2021)
    Table 28. Global Transdermal Drug Delivery System Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global Transdermal Drug Delivery System Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global Transdermal Drug Delivery System Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global Transdermal Drug Delivery System Revenue Market Share by Application (2016-2021)
    Table 32. Global Transdermal Drug Delivery System Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global Transdermal Drug Delivery System Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America Transdermal Drug Delivery System Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America Transdermal Drug Delivery System Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America Transdermal Drug Delivery System Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America Transdermal Drug Delivery System Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America Transdermal Drug Delivery System Market Size by Country (2016-2021) & (US$ Million) 
    Table 39. North America Transdermal Drug Delivery System Market Size by Country (2022-2027) & (US$ Million) 
    Table 40. Europe Transdermal Drug Delivery System Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe Transdermal Drug Delivery System Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe Transdermal Drug Delivery System Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe Transdermal Drug Delivery System Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe Transdermal Drug Delivery System Market Size by Country (2016-2021) & (US$ Million) 
    Table 45. Europe Transdermal Drug Delivery System Market Size by Country (2022-2027) & (US$ Million) 
    Table 46. Asia-Pacific Transdermal Drug Delivery System Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Transdermal Drug Delivery System Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Transdermal Drug Delivery System Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Transdermal Drug Delivery System Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Transdermal Drug Delivery System Market Size by Region (2016-2021) & (US$ Million) 
    Table 51. Asia-Pacific Transdermal Drug Delivery System Market Size by Region (2022-2027) & (US$ Million) 
    Table 52. Latin America Transdermal Drug Delivery System Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America Transdermal Drug Delivery System Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America Transdermal Drug Delivery System Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America Transdermal Drug Delivery System Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America Transdermal Drug Delivery System Market Size by Country (2016-2021) & (US$ Million) 
    Table 57. Latin America Transdermal Drug Delivery System Market Size by Country (2022-2027) & (US$ Million) 
    Table 58. Middle East & Africa Transdermal Drug Delivery System Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Transdermal Drug Delivery System Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Transdermal Drug Delivery System Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Transdermal Drug Delivery System Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2016-2021) & (US$ Million) 
    Table 63. Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2022-2027) & (US$ Million) 
    Table 64. Hisamitsu Company Details
    Table 65. Hisamitsu Business Overview
    Table 66. Hisamitsu Transdermal Drug Delivery System Product
    Table 67. Hisamitsu Revenue in Transdermal Drug Delivery System Business (2016-2021) & (US$ Million)
    Table 68. Hisamitsu Recent Development
    Table 69. Mylan Company Details
    Table 70. Mylan Business Overview
    Table 71. Mylan Transdermal Drug Delivery System Product
    Table 72. Mylan Revenue in Transdermal Drug Delivery System Business (2016-2021) & (US$ Million)
    Table 73. Mylan Recent Development
    Table 74. GSK Company Details
    Table 75. GSK Business Overview
    Table 76. GSK Transdermal Drug Delivery System Product
    Table 77. GSK Revenue in Transdermal Drug Delivery System Business (2016-2021) & (US$ Million)
    Table 78. GSK Recent Development
    Table 79. Novartis Company Details
    Table 80. Novartis Business Overview
    Table 81. Novartis Transdermal Drug Delivery System Product
    Table 82. Novartis Revenue in Transdermal Drug Delivery System Business (2016-2021) & (US$ Million)
    Table 83. Novartis Recent Development
    Table 84. Teve (Actavis) Company Details
    Table 85. Teve (Actavis) Business Overview
    Table 86. Teve (Actavis) Transdermal Drug Delivery System Product
    Table 87. Teve (Actavis) Revenue in Transdermal Drug Delivery System Business (2016-2021) & (US$ Million)
    Table 88. Teve (Actavis) Recent Development
    Table 89. Johnson & Johnson Company Details
    Table 90. Johnson & Johnson Business Overview
    Table 91. Johnson & Johnson Transdermal Drug Delivery System Product
    Table 92. Johnson & Johnson Revenue in Transdermal Drug Delivery System Business (2016-2021) & (US$ Million)
    Table 93. Johnson & Johnson Recent Development
    Table 94. Lohmann Company Details
    Table 95. Lohmann Business Overview
    Table 96. Lohmann Transdermal Drug Delivery System Product
    Table 97. Lohmann Revenue in Transdermal Drug Delivery System Business (2016-2021) & (US$ Million)
    Table 98. Lohmann Recent Development
    Table 99. Teikoku Seiyaku Company Details
    Table 100. Teikoku Seiyaku Business Overview
    Table 101. Teikoku Seiyaku Revenue in Transdermal Drug Delivery System Business (2016-2021) & (US$ Million)
    Table 102. Teikoku Seiyaku Recent Development
    Table 103. Bayer Company Details
    Table 104. Bayer Business Overview
    Table 105. Bayer Transdermal Drug Delivery System Product
    Table 106. Bayer Revenue in Transdermal Drug Delivery System Business (2016-2021) & (US$ Million)
    Table 107. Bayer Recent Development
    Table 108. Lingrui Company Details
    Table 109. Lingrui Business Overview
    Table 110. Lingrui Transdermal Drug Delivery System Product
    Table 111. Lingrui Revenue in Transdermal Drug Delivery System Business (2016-2021) & (US$ Million)
    Table 112. Lingrui Recent Development
    Table 113. Sanofi Company Details
    Table 114. Sanofi Business Overview
    Table 115. Sanofi Transdermal Drug Delivery System Product
    Table 116. Sanofi Revenue in Transdermal Drug Delivery System Business (2016-2021) & (US$ Million)
    Table 117. Sanofi Recent Development
    Table 118. Qizheng Company Details
    Table 119. Qizheng Business Overview
    Table 120. Qizheng Transdermal Drug Delivery System Product
    Table 121. Qizheng Revenue in Transdermal Drug Delivery System Business (2016-2021) & (US$ Million)
    Table 122. Qizheng Recent Development
    Table 123. Endo Company Details
    Table 124. Endo Business Overview
    Table 125. Endo Transdermal Drug Delivery System Product
    Table 126. Endo Revenue in Transdermal Drug Delivery System Business (2016-2021) & (US$ Million)
    Table 127. Endo Recent Development
    Table 128. Huarun 999 Company Details
    Table 129. Huarun 999 Business Overview
    Table 130. Huarun 999 Transdermal Drug Delivery System Product
    Table 131. Huarun 999 Revenue in Transdermal Drug Delivery System Business (2016-2021) & (US$ Million)
    Table 132. Huarun 999 Recent Development
    Table 133. Haw Par Company Details
    Table 134. Haw Par Business Overview
    Table 135. Haw Par Transdermal Drug Delivery System Product
    Table 136. Haw Par Revenue in Transdermal Drug Delivery System Business (2016-2021) & (US$ Million)
    Table 137. Haw Par Recent Development
    Table 138. Nichiban Company Details
    Table 139. Nichiban Business Overview
    Table 140. Nichiban Transdermal Drug Delivery System Product
    Table 141. Nichiban Revenue in Transdermal Drug Delivery System Business (2016-2021) & (US$ Million)
    Table 142. Nichiban Recent Development
    Table 143. Mentholatum Company Details
    Table 144. Mentholatum Business Overview
    Table 145. Mentholatum Transdermal Drug Delivery System Product
    Table 146. Mentholatum Revenue in Transdermal Drug Delivery System Business (2016-2021) & (US$ Million)
    Table 147. Mentholatum Recent Development
    Table 148. Laboratoires Genevrier Company Details
    Table 149. Laboratoires Genevrier Business Overview
    Table 150. Laboratoires Genevrier Transdermal Drug Delivery System Product
    Table 151. Laboratoires Genevrier Revenue in Transdermal Drug Delivery System Business (2016-2021) & (US$ Million)
    Table 152. Laboratoires Genevrier Recent Development
    Table 153. Research Programs/Design for This Report
    Table 154. Key Data Information from Secondary Sources
    Table 155. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Transdermal Drug Delivery System Market Share by Type: 2020 VS 2027
    Figure 2. Fentanyl Features
    Figure 3. Nitroglycerin Features
    Figure 4. Estradiol Features
    Figure 5. Nicotine Features
    Figure 6. Other Features
    Figure 7. Global Transdermal Drug Delivery System Market Share by Application: 2020 VS 2027
    Figure 8. OTC Case Studies
    Figure 9. Rx Case Studies
    Figure 10. Transdermal Drug Delivery System Report Years Considered
    Figure 11. Global Transdermal Drug Delivery System Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Transdermal Drug Delivery System Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Transdermal Drug Delivery System Market Share by Regions: 2020 VS 2027
    Figure 14. Global Transdermal Drug Delivery System Market Share by Regions (2022-2027)
    Figure 15. Global Transdermal Drug Delivery System Market Share by Players in 2020
    Figure 16. Global Top Transdermal Drug Delivery System Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Drug Delivery System as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Transdermal Drug Delivery System Revenue in 2020
    Figure 18. Global Transdermal Drug Delivery System Revenue Market Share by Type (2016-2021)
    Figure 19. Global Transdermal Drug Delivery System Revenue Market Share by Type (2022-2027)
    Figure 20. North America Transdermal Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Transdermal Drug Delivery System Market Share by Type (2016-2027)
    Figure 22. North America Transdermal Drug Delivery System Market Share by Application (2016-2027)
    Figure 23. North America Transdermal Drug Delivery System Market Share by Country (2016-2027)
    Figure 24. United States Transdermal Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Transdermal Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Transdermal Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Transdermal Drug Delivery System Market Share by Type (2016-2027)
    Figure 28. Europe Transdermal Drug Delivery System Market Share by Application (2016-2027)
    Figure 29. Europe Transdermal Drug Delivery System Market Share by Country (2016-2027)
    Figure 30. Germany Transdermal Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Transdermal Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Transdermal Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Transdermal Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Transdermal Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Transdermal Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Transdermal Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Transdermal Drug Delivery System Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Transdermal Drug Delivery System Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Transdermal Drug Delivery System Market Share by Region (2016-2027)
    Figure 40. China Transdermal Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Transdermal Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Transdermal Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Transdermal Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Transdermal Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Transdermal Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Transdermal Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Transdermal Drug Delivery System Market Share by Type (2016-2027)
    Figure 48. Latin America Transdermal Drug Delivery System Market Share by Application (2016-2027)
    Figure 49. Latin America Transdermal Drug Delivery System Market Share by Country (2016-2027)
    Figure 50. Mexico Transdermal Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Transdermal Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Transdermal Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Transdermal Drug Delivery System Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Transdermal Drug Delivery System Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Transdermal Drug Delivery System Market Share by Country (2016-2027)
    Figure 56. Turkey Transdermal Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Transdermal Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Transdermal Drug Delivery System Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Hisamitsu Revenue Growth Rate in Transdermal Drug Delivery System Business (2016-2021)
    Figure 60. Mylan Revenue Growth Rate in Transdermal Drug Delivery System Business (2016-2021)
    Figure 61. GSK Revenue Growth Rate in Transdermal Drug Delivery System Business (2016-2021)
    Figure 62. Novartis Revenue Growth Rate in Transdermal Drug Delivery System Business (2016-2021)
    Figure 63. Teve (Actavis) Revenue Growth Rate in Transdermal Drug Delivery System Business (2016-2021)
    Figure 64. Johnson & Johnson Revenue Growth Rate in Transdermal Drug Delivery System Business (2016-2021)
    Figure 65. Lohmann Revenue Growth Rate in Transdermal Drug Delivery System Business (2016-2021)
    Figure 66. Teikoku Seiyaku Revenue Growth Rate in Transdermal Drug Delivery System Business (2016-2021)
    Figure 67. Bayer Revenue Growth Rate in Transdermal Drug Delivery System Business (2016-2021)
    Figure 68. Lingrui Revenue Growth Rate in Transdermal Drug Delivery System Business (2016-2021)
    Figure 69. Sanofi Revenue Growth Rate in Transdermal Drug Delivery System Business (2016-2021)
    Figure 70. Qizheng Revenue Growth Rate in Transdermal Drug Delivery System Business (2016-2021)
    Figure 71. Endo Revenue Growth Rate in Transdermal Drug Delivery System Business (2016-2021)
    Figure 72. Huarun 999 Revenue Growth Rate in Transdermal Drug Delivery System Business (2016-2021)
    Figure 73. Haw Par Revenue Growth Rate in Transdermal Drug Delivery System Business (2016-2021)
    Figure 74. Nichiban Revenue Growth Rate in Transdermal Drug Delivery System Business (2016-2021)
    Figure 75. Mentholatum Revenue Growth Rate in Transdermal Drug Delivery System Business (2016-2021)
    Figure 76. Laboratoires Genevrier Revenue Growth Rate in Transdermal Drug Delivery System Business (2016-2021)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
Frequently Asked Questions
Transdermal Drug Delivery System report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Transdermal Drug Delivery System report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Transdermal Drug Delivery System report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Bearings

Bearings market is segmented by company, region (country), by Type, and by Application. Players,  ... Read More

Game Engines

Game Engines market is segmented by company, region (country), by Type, and by Application. Playe ... Read More